Literature DB >> 25964079

Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma by derepression of CTNNB1.

Sheng-xian Yuan1, Jie Wang2, Fu Yang3, Qi-fei Tao1, Jin Zhang1, Li-li Wang1, Yuan Yang1, Hui Liu1, Zhen-guang Wang1, Qing-guo Xu1, Jia Fan4, Lei Liu5, Shu-han Sun3, Wei-ping Zhou1.   

Abstract

UNLABELLED: Tumor cells with stemness (stem-cell) features contribute to initiation and progression of hepatocellular carcinoma (HCC), but involvement of long noncoding RNAs (lncRNAs) remains largely unclear. Genome-wide analyses were applied to identify tumor-associated lncRNA-DANCR. DANCR expression level and prognostic values of DANCR were assayed in two HCC cohorts (China and Korea, n = 135 and 223). Artificial modulation of DANCR (down- and overexpression) was done to explore the role of DANCR in tumorigenesis and colonization, and tumor-bearing mice were used to determine therapeutic effects. We found that lncRNA-DANCR is overexpressed in stem-like HCC cells, and this can serve as a prognostic biomarker for HCC patients. Experiments showed that DANCR markedly increased stemness features of HCC cells to promote tumorigenesis and intra-/extrahepatic tumor colonization. Conversely, DANCR knockdown attenuated the stem-cell properties and in vivo interference with DANCR action led to decreased tumor cell vitality, tumor shrinkage, and improved mouse survival. Additionally, we found that the role of DANCR relied largely on an association with, and regulation of, CTNNB1. Association of DANCR with CTNNB1 blocked the repressing effect of microRNA (miR)-214, miR-320a, and miR-199a on CTNNB1. This observation was confirmed in vivo, suggesting a novel mechanism of tumorigenesis involving lncRNAs, messenger RNAs, and microRNAs.
CONCLUSIONS: These studies reveal a significance and mechanism of DANCR action in increasing stemness features and offer a potential prognostic marker and a therapeutic target for HCC.
© 2015 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25964079     DOI: 10.1002/hep.27893

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  169 in total

1.  Sox4 enhances chondrogenic differentiation and proliferation of human synovium-derived stem cell via activation of long noncoding RNA DANCR.

Authors:  Lei Zhang; Shuo Chen; Nirong Bao; Chao Yang; Yunfan Ti; Liwu Zhou; Jianning Zhao
Journal:  J Mol Histol       Date:  2015-10-29       Impact factor: 2.611

2.  MYC Targeted Long Noncoding RNA DANCR Promotes Cancer in Part by Reducing p21 Levels.

Authors:  Yunqi Lu; Zhongyi Hu; Lingegowda S Mangala; Zachary E Stine; Xiaowen Hu; Dahai Jiang; Yan Xiang; Youyou Zhang; Sunila Pradeep; Cristian Rodriguez-Aguayo; Gabriel Lopez-Berestein; Angelo M DeMarzo; Anil K Sood; Lin Zhang; Chi V Dang
Journal:  Cancer Res       Date:  2017-11-27       Impact factor: 12.701

Review 3.  Advances in the role of exosomal non-coding RNA in the development, diagnosis, and treatment of gastric cancer (Review).

Authors:  Peng-Fei Gao; Da Huang; Jun-Yan Wen; Wei Liu; Hong-Wu Zhang
Journal:  Mol Clin Oncol       Date:  2020-06-10

4.  Integrative classification of human coding and noncoding genes through RNA metabolism profiles.

Authors:  Neelanjan Mukherjee; Lorenzo Calviello; Antje Hirsekorn; Stefano de Pretis; Mattia Pelizzola; Uwe Ohler
Journal:  Nat Struct Mol Biol       Date:  2016-11-21       Impact factor: 15.369

5.  A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer.

Authors:  Po-Shun Wang; Cheng-Han Chou; Cheng-Han Lin; Yun-Chin Yao; Hui-Chuan Cheng; Hao-Yi Li; Yu-Chung Chuang; Chia-Ning Yang; Luo-Ping Ger; Yu-Chia Chen; Forn-Chia Lin; Tang-Long Shen; Michael Hsiao; Pei-Jung Lu
Journal:  Oncogene       Date:  2018-05-14       Impact factor: 9.867

6.  EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.

Authors:  Ting Lei; Xiaodong Zhu; Kai Zhu; Fuxin Jia; Siqiao Li
Journal:  Cancer Biol Ther       Date:  2019-03-31       Impact factor: 4.742

Review 7.  The Emerging Function and Mechanism of ceRNAs in Cancer.

Authors:  Yunfei Wang; Jiakai Hou; Dandan He; Ming Sun; Peng Zhang; Yonghao Yu; Yiwen Chen
Journal:  Trends Genet       Date:  2016-02-24       Impact factor: 11.639

8.  Systemic Delivery of Tumor-Targeting siRNA Nanoparticles against an Oncogenic LncRNA Facilitates Effective Triple-Negative Breast Cancer Therapy.

Authors:  Amita M Vaidya; Zhanhu Sun; Nadia Ayat; Andrew Schilb; Xujie Liu; Hongfa Jiang; Da Sun; Josef Scheidt; Victoria Qian; Siyuan He; Hannah Gilmore; William P Schiemann; Zheng-Rong Lu
Journal:  Bioconjug Chem       Date:  2019-02-21       Impact factor: 4.774

9.  Knockdown of differentiation antagonizing non-protein coding RNA exerts anti-tumor effect by up-regulating miR-214 in endometrial carcinoma.

Authors:  Jingli Sun; Shaofeng Gao; Cuihua Lu
Journal:  Mol Cell Biochem       Date:  2019-06-03       Impact factor: 3.396

10.  Over-expression of lncRNA DANCR is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer.

Authors:  Yang Liu; Meng Zhang; Lei Liang; Jian Li; Yu-Xin Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.